(R)-Methyl 5-(4-(6-benzyl-4,5-dimethylpyridazin-3-yl)-2-methylpiperazin-1-yl)pyrazine-2-carboxylate, 98%, 1g

(2,6-Dibromophenyl)methanamine, 95.0%, 250mg

3-(Bromomethyl)pyridazine hydrobromide, 95.0%, 100mg

(S)-2-(Benzo[b]thiophen-2-yl)-4-benzyl-4,5-dihydrooxazole, 97%, 100mg

Methyl 5-bromo-3-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-2-methylbenzoate, 98%, 250mg

(R)-1-(9H-FLUOREN-9-YL)-10-ISOPROPYL-13,13-DIMETHYL-3,11-DIOXO-2,12-DIOXA-4,10-DIAZATETRADECANE-5-CARBOXYLIC ACID, 95%, 1g

2,5-Dioxopyrrolidin-1-yl 14-oxo-18-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-4,7,10-trioxa-13-azaoctadecanoate, 95%, 1g

4-(3,4-Difluorophenoxy)benzaldehyde, 97%, 250mg

4-Hydroxybenzamide, 98.0%, 5g

Dichtung Silikon/PTFE, GL 45, Ø 43,2 mm, 5 Stück

Reaktoren für die Peptidsynthese, 2 ml, 100 Stück, 100 Stück

(1R,3R,5R,7R)-6-TOSYL-2-OXA-6-AZAADAMANTANE, 95.0%, 250mg

Tetrakis(2-methoxyethoxy)silane, 95+%, 100g